Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Daytrader goes Postal -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (105)	7/31/1999 12:32:00 PM
From: gao seng	Read Replies (1) \| Respond to of 193

Searching the MEDLINE database at the National Library of Medicine website (http://igm.nlm.nih.gov) I found a study by doctors from the Hadassah-Hebrew University School of Medicine in Jerusalem, Israel that came to this conclusion about Luvox, or fluvoxamine: "Our case series suggests that fluvoxamine may have the ability to induce or unmask manic behavior in depressed patients. Clinicians are alerted to monitor for this 'switching' effect..." TITLE: Fluvoxamine-associated manic behavior: a case series. AUTHORS: Dorevitch A; Frankel Y; Bar-Halperin A; Aronzon R; Zilberman L SOURCE: Ann Pharmacother 1993 Dec;27(12):1455-7 CITATION IDS: PMID: 8305775 UI: 94138126